Thanks, spuddy. There's not much to say on this stock these days. Quarterly due on Tuesday will at least tell the market how many bikkies they have in the tin. At September 30 they had $2.55 m. Add in the R&D of $1.26 m. Total $3.71 m (about 0.4 cps). My guesstimate for cash at December 31 would be around $2.5 m, giving them until June 30 to survive without finding additional funds.
- Forums
- ASX - By Stock
- NOR
- Execution of a Material Commercial Agreement
Execution of a Material Commercial Agreement, page-337
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOR (ASX) to my watchlist
|
|||||
Last
4.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.32M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 4.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.7¢ | 61224 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.044 |
1 | 70000 | 0.042 |
1 | 13888 | 0.041 |
2 | 475000 | 0.040 |
1 | 75000 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 61224 | 1 |
0.049 | 49000 | 1 |
0.050 | 520000 | 3 |
0.056 | 60000 | 1 |
0.058 | 100000 | 1 |
Last trade - 16.12pm 03/07/2024 (20 minute delay) ? |
Featured News
NOR (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online